About enVVeno Medical
enVVeno Medical is a company based in Irvine (United States) founded in 1999 by Norman Jaffe. enVVeno Medical has raised $874 thousand across 6 funding rounds from investors including Perceptive Advisors, L1 Capital and Nantahala Capital Management. The company has 37 employees as of December 31, 2024. enVVeno Medical operates in a competitive market with competitors including Tactile Medical, Intervene, Sky Medical Technology, DeVoro Medical and Micro Medical Solutions, among others.
- Headquarter Irvine, United States
- Employees 37 as on 31 Dec, 2024
- Founders Norman Jaffe
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
-$21.82 M (USD)7.22as on Dec 31, 2024
-
EBITDA
-$23.3 M (USD)5.65as on Dec 31, 2024
-
Total Equity Funding
$874 K (USD)
in 6 rounds
-
Latest Funding Round
$28 M (USD), Post-IPO
Oct 06, 2023
-
Investors
Perceptive Advisors
& 4 more
-
Employee Count
37
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of enVVeno Medical
enVVeno Medical is a publicly listed company on the NASDAQ with ticker symbol NVNO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of enVVeno Medical
enVVeno Medical has successfully raised a total of $874K across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $28 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in enVVeno Medical
enVVeno Medical has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Perceptive Advisors, L1 Capital and Nantahala Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Fundamentally-driven firm investing in micro-cap stocks with long and short strategies.
|
Locked | Locked | Locked |
Investor details for enVVeno Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by enVVeno Medical
Investment portfolio details for enVVeno Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - enVVeno Medical
Detailed financials for enVVeno Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Envveno Medical Comparisons
Peer comparison for enVVeno Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of enVVeno Medical
enVVeno Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tactile Medical, Intervene, Sky Medical Technology, DeVoro Medical and Micro Medical Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Home therapy devices for lymphedema and venous ulcers are provided.
|
|
| Locked | Locked | Locked |
Catheter-based therapy for chronic venous insufficiency is developed.
|
|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
Medical devices for treating cardiac diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of a device for CLI and PAD patients to prevent amputation
|
Detailed competitors of enVVeno Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Envveno Medical
Complete news archive for enVVeno Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about enVVeno Medical
enVVeno Medical was founded in 1999 and raised its 1st funding round 16 years after it was founded.
enVVeno Medical is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Robert Berman is the current CEO of enVVeno Medical.
enVVeno Medical is a funded company, having raised a total of $874K across 6 funding rounds to date.
As of Dec 31, 2024, the latest employee count at enVVeno Medical is 37.
Developer of medical device for the the treatment of venous diseases. The company is focused on the development of bioprosthetic solutions VenoValve an implant for the treatment of deep venous chronic venous insufficiency to assist in propelling blood up the leg, and back to the heart and lungs.
enVVeno Medical's top competitors include Tactile Medical, Intervene and Sky Medical Technology.
Yes, enVVeno Medical is publicly traded on NASDAQ under the ticker symbol NVNO.
enVVeno Medical has 5 investors. Key investors include Perceptive Advisors, L1 Capital, Nantahala Capital Management, Kingdon Capital Management, and Velan Capital.
The ticker symbol of enVVeno Medical is NVNO on NASDAQ.